(-)-epigallocatechin 3-gallate multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of FXYD5 mRNA CTD PMID:22079256 1,2-dimethylhydrazine increases expression ISO Fxyd5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of FXYD5 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FXYD5 mRNA CTD PMID:25380136 17alpha-ethynylestradiol multiple interactions ISO Fxyd5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FXYD5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of FXYD5 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of FXYD5 mRNA CTD PMID:30165855 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:31826744 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Fxyd5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FXYD5 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FXYD5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FXYD5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Fxyd5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of FXYD5 mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fxyd5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FXYD5 mRNA CTD PMID:21570461 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of FXYD5 mRNA CTD PMID:23537331 2,4-diaminotoluene increases expression ISO Fxyd5 (Mus musculus) 6480464 2 and 4-diaminotoluene results in increased expression of FXYD5 mRNA CTD PMID:20713471 2-palmitoylglycerol increases expression ISO FXYD5 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of FXYD5 mRNA CTD PMID:37199045 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FXYD5 mRNA CTD PMID:28628672 3-methylcholanthrene increases expression ISO Fxyd5 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of FXYD5 mRNA CTD PMID:20713471 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of FXYD5 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO Fxyd5 (Mus musculus) 6480464 bisphenol S results in increased expression of FXYD5 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine affects expression ISO FXYD5 (Homo sapiens) 6480464 Decitabine affects the expression of FXYD5 mRNA CTD PMID:23300844 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FXYD5 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FXYD5 mRNA CTD PMID:30047161 acetamide increases expression EXP 6480464 acetamide results in increased expression of FXYD5 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO FXYD5 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of FXYD5 protein CTD PMID:20106945 aldehydo-D-glucose increases expression ISO Fxyd5 (Mus musculus) 6480464 Glucose results in increased expression of FXYD5 mRNA CTD PMID:17178593 all-trans-retinoic acid increases expression ISO FXYD5 (Homo sapiens) 6480464 Tretinoin results in increased expression of FXYD5 mRNA CTD PMID:33167477 amitrole increases expression EXP 6480464 Amitrole results in increased expression of FXYD5 mRNA CTD PMID:30047161 antirheumatic drug decreases expression ISO FXYD5 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of FXYD5 mRNA CTD PMID:24449571 benzo[a]pyrene decreases expression ISO Fxyd5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of FXYD5 mRNA CTD PMID:20127859 benzo[a]pyrene increases expression ISO FXYD5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of FXYD5 mRNA CTD PMID:32234424 benzo[a]pyrene increases expression ISO Fxyd5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of FXYD5 mRNA CTD PMID:22228805 and PMID:32417428 benzo[a]pyrene multiple interactions ISO Fxyd5 (Mus musculus) 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of FXYD5 mRNA] CTD PMID:22228805 benzo[b]fluoranthene increases expression ISO Fxyd5 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of FXYD5 mRNA CTD PMID:26377693 Benzo[ghi]perylene decreases expression ISO Fxyd5 (Mus musculus) 6480464 1 and 12-benzoperylene results in decreased expression of FXYD5 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate increases expression ISO FXYD5 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of FXYD5 mRNA CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of FXYD5 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO Fxyd5 (Mus musculus) 6480464 bisphenol A results in decreased expression of FXYD5 mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FXYD5 mRNA CTD PMID:30816183 more ... bisphenol A increases expression ISO Fxyd5 (Mus musculus) 6480464 bisphenol A results in increased expression of FXYD5 mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FXYD5 mRNA CTD PMID:28628672 bisphenol F increases expression ISO Fxyd5 (Mus musculus) 6480464 bisphenol F results in increased expression of FXYD5 mRNA CTD PMID:30951980 butan-1-ol multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FXYD5 mRNA CTD PMID:29432896 cadmium atom multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FXYD5 mRNA and [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FXYD5 mRNA CTD PMID:29741670 and PMID:35301059 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of FXYD5 mRNA CTD PMID:25993096 cadmium dichloride multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FXYD5 mRNA and [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FXYD5 mRNA CTD PMID:29741670 and PMID:35301059 carbamazepine affects expression ISO FXYD5 (Homo sapiens) 6480464 Carbamazepine affects the expression of FXYD5 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO Fxyd5 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of FXYD5 mRNA CTD PMID:19395590 CGP 52608 multiple interactions ISO FXYD5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to FXYD5 gene] CTD PMID:28238834 choline multiple interactions ISO Fxyd5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FXYD5 mRNA CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of FXYD5 mRNA CTD PMID:22023808 cisplatin affects expression ISO FXYD5 (Homo sapiens) 6480464 Cisplatin affects the expression of FXYD5 mRNA CTD PMID:23300844 clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of FXYD5 mRNA CTD PMID:30047161 copper atom multiple interactions ISO Fxyd5 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of FXYD5 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO Fxyd5 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of FXYD5 mRNA CTD PMID:15467011 copper(II) sulfate increases expression ISO FXYD5 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of FXYD5 mRNA CTD PMID:19549813 cyclosporin A increases expression ISO FXYD5 (Homo sapiens) 6480464 Cyclosporine results in increased expression of FXYD5 mRNA CTD PMID:20106945 and PMID:25562108 D-glucose increases expression ISO Fxyd5 (Mus musculus) 6480464 Glucose results in increased expression of FXYD5 mRNA CTD PMID:17178593 dexamethasone multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FXYD5 mRNA CTD PMID:28628672 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of FXYD5 mRNA CTD PMID:21266533 disodium selenite increases expression ISO FXYD5 (Homo sapiens) 6480464 Sodium Selenite results in increased expression of FXYD5 mRNA CTD PMID:18175754 diuron increases expression EXP 6480464 Diuron results in increased expression of FXYD5 mRNA CTD PMID:21551480 and PMID:25152437 dorsomorphin multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO FXYD5 (Homo sapiens) 6480464 Doxorubicin affects the expression of FXYD5 mRNA CTD PMID:29803840 entinostat increases expression ISO FXYD5 (Homo sapiens) 6480464 entinostat results in increased expression of FXYD5 mRNA CTD PMID:26272509 and PMID:27188386 entinostat multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FXYD5 mRNA CTD PMID:27188386 folic acid multiple interactions ISO Fxyd5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FXYD5 mRNA CTD PMID:20938992 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of FXYD5 mRNA CTD PMID:22061828 glucose increases expression ISO Fxyd5 (Mus musculus) 6480464 Glucose results in increased expression of FXYD5 mRNA CTD PMID:17178593 hydralazine multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of FXYD5 mRNA CTD PMID:17183730 hydrogen peroxide increases expression ISO Fxyd5 (Mus musculus) 6480464 Hydrogen Peroxide results in increased expression of FXYD5 mRNA CTD PMID:14729362 indometacin multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FXYD5 mRNA CTD PMID:28628672 L-methionine multiple interactions ISO Fxyd5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FXYD5 mRNA CTD PMID:20938992 lead(0) affects expression ISO FXYD5 (Homo sapiens) 6480464 Lead affects the expression of FXYD5 mRNA CTD PMID:28903495 lipopolysaccharide increases expression ISO FXYD5 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of FXYD5 mRNA CTD PMID:35953652 lithium chloride increases expression ISO FXYD5 (Homo sapiens) 6480464 Lithium Chloride results in increased expression of FXYD5 mRNA CTD PMID:23527032 methimazole increases expression EXP 6480464 Methimazole results in increased expression of FXYD5 mRNA CTD PMID:30047161 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of FXYD5 mRNA CTD PMID:21515302 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of FXYD5 mRNA CTD PMID:25380136 nickel atom increases expression ISO FXYD5 (Homo sapiens) 6480464 Nickel results in increased expression of FXYD5 mRNA CTD PMID:24768652 and PMID:25583101 O-methyleugenol increases expression ISO FXYD5 (Homo sapiens) 6480464 methyleugenol results in increased expression of FXYD5 mRNA CTD PMID:32234424 ozone increases expression EXP 6480464 Ozone results in increased expression of FXYD5 mRNA CTD PMID:16716893 paracetamol affects expression ISO Fxyd5 (Mus musculus) 6480464 Acetaminophen affects the expression of FXYD5 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of FXYD5 mRNA CTD PMID:33387578 paracetamol increases expression ISO FXYD5 (Homo sapiens) 6480464 Acetaminophen results in increased expression of FXYD5 mRNA CTD PMID:29067470 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of FXYD5 mRNA CTD PMID:18158353 potassium chromate increases expression ISO FXYD5 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of FXYD5 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of FXYD5 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile decreases expression ISO Fxyd5 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of FXYD5 mRNA CTD PMID:22698814 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of FXYD5 mRNA CTD PMID:20726854 quercetin increases expression ISO FXYD5 (Homo sapiens) 6480464 Quercetin results in increased expression of FXYD5 mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sevoflurane increases expression ISO FXYD5 (Homo sapiens) 6480464 Sevoflurane results in increased expression of FXYD5 mRNA CTD PMID:35953652 Soman increases expression EXP 6480464 Soman results in increased expression of FXYD5 mRNA CTD PMID:19281266 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of FXYD5 mRNA CTD PMID:30047161 sunitinib increases expression ISO FXYD5 (Homo sapiens) 6480464 Sunitinib results in increased expression of FXYD5 mRNA CTD PMID:31533062 tert-butyl hydroperoxide increases expression ISO Fxyd5 (Mus musculus) 6480464 tert-Butylhydroperoxide results in increased expression of FXYD5 mRNA CTD PMID:14729362 and PMID:15003993 tert-butyl hydroperoxide increases expression ISO FXYD5 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of FXYD5 mRNA CTD PMID:15336504 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of FXYD5 mRNA CTD PMID:21515302 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FXYD5 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO Fxyd5 (Mus musculus) 6480464 titanium dioxide results in increased expression of FXYD5 mRNA CTD PMID:23557971 trichostatin A increases expression ISO FXYD5 (Homo sapiens) 6480464 trichostatin A results in increased expression of FXYD5 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FXYD5 mRNA CTD PMID:27188386 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of FXYD5 mRNA CTD PMID:21515302 troglitazone increases expression ISO FXYD5 (Homo sapiens) 6480464 troglitazone results in increased expression of FXYD5 mRNA CTD PMID:25572481 tungsten decreases expression ISO Fxyd5 (Mus musculus) 6480464 Tungsten results in decreased expression of FXYD5 mRNA CTD PMID:30912803 valproic acid multiple interactions ISO FXYD5 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of FXYD5 mRNA more ... CTD PMID:17183730 and PMID:27188386 valproic acid increases expression ISO FXYD5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of FXYD5 mRNA CTD PMID:26272509 and PMID:28001369 vancomycin decreases expression ISO Fxyd5 (Mus musculus) 6480464 Vancomycin results in decreased expression of FXYD5 mRNA CTD PMID:18930951 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of FXYD5 mRNA CTD PMID:22570695
